The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Detecting prostate cancer in BRCA1 and BRCA2 mutation carriers: A role for EN2?
Emma Killick
No relevant relationships to disclose
Richard Morgan
No relevant relationships to disclose
Francesca Launchbury
No relevant relationships to disclose
Nicola E. Annels
No relevant relationships to disclose
Elizabeth Bancroft
No relevant relationships to disclose
Elizabeth Page
No relevant relationships to disclose
Elena Castro
No relevant relationships to disclose
Zsofia Kote-Jarai
No relevant relationships to disclose
Ros A. Eeles
No relevant relationships to disclose
Hardev S. Pandha
No relevant relationships to disclose